ArticleHepatology international2013
Spontaneous bacterial empyema in patients with liver cirrhosis in Upper Egypt: prevalence and causative organisms.
Article in Hepatology international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 13 citations in OpenAlex.
- KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications 2026.Clinical and molecular hepatology · 2026Article
- Global Prevalence, Temporal Trends, and Associated Mortality of Bacterial Infections in Patients with Liver Cirrhosis: A Meta-analysis.Journal of clinical and translational hepatology · 2025Article
- [Pulmonary Complications in Patients with Liver Cirrhosis].The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2023Review
- Spontaneous bacterial empyema in cirrhosis: A systematic review and meta-analysis.World journal of hepatology · 2022Article
- Rare Presentation of Isolated Spontaneous Bacterial Empyema without Concomitant Ascites in a Patient with Cirrhosis.Middle East journal of digestive diseases · 2022Article
- Empyema Tube or No Tube?Cureus · 2021Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSpontaneous bacterial empyema (SBEM) is a complication in cirrhotic patients, in which a preexisting pleural effusion becomes infected. PURPOSE: The purpose was to determine the prevalence and causative organisms of SBEM among cirrhotic patients with hydrothorax. MATERIALS AND
methodsThis descriptive, cross-sectional study included 901 cirrhotic patients. All patients underwent clinical evaluation, liver function tests, chest X-ray, abdominal and chest ultrasonography, and pleural and peritoneal fluids study (when detected) including polymorphonuclear (PMN) leukocyte count, biochemical analysis, and culture by two methods: conventional and modified (inoculation of 10 mL of pleural or peritoneal fluid into a blood culture bottle). Diagnostic criteria for SBEM included positive pleural fluid culture and a PMN count of >250 cells/mm(3) or, if a negative culture, a pleural fluid PMN count of >500 cells/mm(3) and the absence of pneumonia on chest radiography.
resultsOf 901 cirrhotic patients, 16 cases of SBEM were diagnosed. The prevalence of SBEM was 1.8 % in cirrhotic patients and 26.2 % in patients with cirrhosis and hydrothorax. Pleural fluid culture was found to be positive by the conventional method in four (25 %) cases and by modified methods in 11 (68.8 %) cases. Escherichia coli was the most frequently isolated pathogen (six cases). The mortality rate of SBEM was 25 %.
conclusionsSBEM is a frequent complication in cirrhotic patients with hydrothorax. E. coli is the most frequent organism responsible for SBEM. The modified method of pleural fluid culture is more sensitive than the conventional method for diagnosis of SBEM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.